Hemispherian AS
PrivateLast Round
Joint Venture
Sep 29, 2025
Total Funding Raised
$10.04M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hemispherian AS is a clinical-stage pharmaceutical company developing a novel class of small molecule drugs that target the TET2 enzyme to treat aggressive cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemispherian AS Comparables
Compare Hemispherian AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curtana Pharmaceuticals | 85% | |
| Oniria Therapeutics | 83% | |
| EPICS Therapeutics | 82% | |
Hemispherian AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Sep 29, 2025 | ||||
| Grant | Dec 15, 2023 | ||||
| Series A | Nov 24, 2022 | ||||
| VC Round | Oct 19, 2022 | ||||
| Grant | Oct 19, 2022 | ||||
Seed | May 3, 2022 |
Key People
Founding team and executive leadership
Hemispherian AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission | Grant |
| Kistefos | Series A |
| Investinor | Seed |
| Meneldor | Seed, Series A |
| Kvantia | Series A |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 343% MoM.
- Sep 29, 2025
Completed a joint venture funding round.
Hemispherian AS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemispherian AS's valuation, stock price, and market status.